Robert F. Kennedy Jr.'s new vaccine advisory committee approved Merck's clesrovimab antibody for RSV protection in infants. The committee, comprised of vaccine skeptics, will also discuss thimerosal, a vaccine preservative falsely linked to autism by anti-vaccine groups. This discussion, prompted by Kennedy, concerns public health experts who fear it could undermine vaccine confidence and access. The committee's decisions significantly impact vaccine coverage and availability in the U.S.

Prepared by Olivia Bennett and reviewed by editorial team.